DEC 08, 2018 10:51 AM PST

Regenerating Beta Cells to Cure Diabetes

WRITTEN BY: Carmen Leitch

It’s been established that cells in the islet of the pancreas called beta cells produce a critical hormone that controls blood sugar - insulin. However, those cells can get tapped out for a variety of reasons, sometimes because they’re overworked or in other cases because the immune system destroys them. Ultimately the loss of those cells results in a lack of insulin and chronically high blood sugar - diabetes. Researchers have long speculated that getting those cells to regrow would be a way to cure diabetes; but first, they have to figure out how if it's possible. 

Writing in Trends in Endocrinology & Metabolism, scientists from the Diabetes Research Institute at the University of Miami (DRI) have now said that progenitor stem cells do exist in the pancreas. These cells, said the scientists, can regenerate in humans. This article is meant to settle a debate about how to coax those cells to grow.

"We have demonstrated that there are progenitors in the adult pancreas, not only in mice but in humans, which is a very important clarification, and that those cells can potentially be stimulated through pharmacological means to induce regeneration in patients with type 1 diabetes. That is the 'Holy Grail' of what we are trying to achieve here at the DRI," explained Juan Dominguez-Bendala, Ph.D., director of pancreatic stem cell development for translational research. He was the co-author of the report with Ricardo Pastori, Ph.D., director of molecular biology.

Decades ago, researchers suggested that progenitor cells lived in the duct of the adult pancreas. That catalyzed investigations into how to stimulate ductal cells to specialize into other types of cells in the pancreas, including those that make insulin. 

A technique called lineage tracing was used later to trace the development of pancreatic cells. It showed that insulin-producing beta cells are replenished when existing cells divide; they were not coming from the growth of fresh ones.

The DRI researchers think that there were flaws in the model used to reach those conclusions. One major caveat was introduced when mice were used; there are huge differences between mouse and human islets.

"The hypothesis that the pancreas harbors progenitor cells has been discredited for a number of years, but we believe that many of the techniques used to reach that conclusion were flawed. We have found profound differences in the behavior of human cells versus mouse cells in the pancreas, and we think it's important to highlight and emphasize the regeneration processes in human cells," explained Dr. Dominguez-Bendala. "Clearly, our work and the work of others is actually contributing to the notion that we have stem cells in the adult pancreas, and that we can potentially exploit those cells to our benefit for the treatment of type 1 diabetes."

Type 1 diabetes happens after the body’s immune system mistakenly attacks pancreatic beta cells and kills them. Patients have to monitor and inject insulin every day — the only ones that don’t have received successful islet transplants. We don’t have enough of those healthy islets to cure every type 1 diabetic, however. A potential solution is getting patients to regrow their own cells.

"If we could give the patient something that will promote the proliferation and subsequent differentiation of those cells that are already in the pancreas into beta cells while controlling autoimmunity, we could harness the natural ability of the body to heal itself. We think that would open a whole new therapeutic horizon," said Dr. Dominguez-Bendala.

 

Sources: AAAS/Eurekalert! Via DRI, Cell ReportsTrends in Endocrinology & Metabolism

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 23, 2020
Cell & Molecular Biology
JAN 23, 2020
Scientists Engineer Venom-Producing Organoids
Snake venom is also a source of therapeutics, and a potential source of new medicines.
FEB 10, 2020
Immunology
FEB 10, 2020
How Cancer Evades the Immune System Time and Time Again
Scientists discovered a new mechanism by which cancer cells evade the immune system to further their own agenda: invade, multiply, and spread. Identifying
MAR 04, 2020
Cell & Molecular Biology
MAR 04, 2020
CRISPR Used Inside of a Patient For the First Time
In a first, scientists have used the CRISPR gene-editing tool inside of a person's body to treat a serious eye disorder.
MAR 18, 2020
Genetics & Genomics
MAR 18, 2020
Finding a Treatment for Fetal Alcohol Spectrum Disorder
When developing fetuses are exposed to any amount of alcohol, they are at risk for a variety of irreversible birth defects.
MAR 22, 2020
Cell & Molecular Biology
MAR 22, 2020
Capturing Images of Firing Neurons
Our bodies run on electricity. Neurons send rapidly fired electrical signals through the brain and limbs constantly, enabling us to think and move.
APR 08, 2020
Immunology
APR 08, 2020
How the Skin Shields Against Zika Infection
Aedes mosquitoes are native of Africa but are commonly found in regions of the Americas, Asia, and the Pacific. These daytime-active bloodsuckers are notor
Loading Comments...